Daniela Tormene
Overview
Explore the profile of Daniela Tormene including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1034
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pelizza M, Martinato M, Rosati A, Nosadini M, Saracco P, Giordano P, et al.
Front Pediatr
. 2024 Feb;
12:1372754.
PMID: 38357512
[This corrects the article DOI: 10.3389/fped.2023.1094246.].
2.
Spiezia L, Campello E, Tormene D, Simioni P
Semin Thromb Hemost
. 2024 Jan;
50(6):866-872.
PMID: 38181816
The incidence of venous thromboembolism (VTE) in the pediatric population has increased more than 10-fold in the last 20 years, as a consequence of the advancement of resuscitation and surgical...
3.
Pelizza M, Martinato M, Rosati A, Nosadini M, Saracco P, Giordano P, et al.
Front Pediatr
. 2023 May;
11:1094246.
PMID: 37152311
Introduction: Thrombotic events in neonates and children represent a rare although severe occurrence in view of the associated risk of mortality and sequelae. Quality evidence is limited in this field,...
4.
Simion C, Campello E, Boccatonda A, Tormene D, Spiezia L, Dalla Valle F, et al.
Intern Emerg Med
. 2022 Dec;
18(3):943-948.
PMID: 36583850
No abstract available.
5.
Prandoni P, Gabara C, Bilora F, Aibar J, Pesavento R, Villalobos A, et al.
Thromb Res
. 2022 Dec;
222:16-19.
PMID: 36549192
No abstract available.
6.
Hoxha A, Tormene D, Campello E, Simioni P
Front Pharmacol
. 2022 Jun;
13:849692.
PMID: 35662738
Different treatment protocols have been employed to manage heparin/low-dose aspirin refractory or high-risk pregnancies in antiphospholipid antibody syndrome (APS) pregnancies. A systematic review of the literature on additional treatments used...
7.
Poletto F, Spiezia L, Simion C, Campello E, Dalla Valle F, Tormene D, et al.
Viruses
. 2022 Apr;
14(4).
PMID: 35458467
Background: Therapeutic/intermediate-dose heparin reduces the risk of thromboembolic events but increases the risk of major bleeding in patients hospitalized for acute COVID-19 pneumonia. Objectives: To prospectively assess the incidence of...
8.
Lasagni D, Nosadini M, Molinari A, Saracco P, Pelizza M, Piersigilli F, et al.
Front Pediatr
. 2022 Apr;
10:843643.
PMID: 35402350
Background: Central venous catheters (CVCs) represent one of the main risk factors for venous thrombotic events (VTEs) in children. Methods: We studied the Italian Registry of Pediatric Thrombosis (RITI) with...
9.
Zanetto A, Campello E, Bulato C, Gavasso S, Farinati F, Russo F, et al.
J Hepatol
. 2022 Apr;
77(3):660-669.
PMID: 35364225
Background & Aims: Studies on platelet aggregation in cirrhosis are controversial because interpretation of platelet function is challenged by thrombocytopenia. We conducted a prospective study to investigate whole blood platelet...
10.
Campello E, Bulato C, Simion C, Spiezia L, Radu C, Gavasso S, et al.
Thromb Haemost
. 2022 Mar;
122(8):1352-1360.
PMID: 35253140
A large number of daily requests to exclude possible prothrombotic risk factors for coronavirus disease 2019 (COVID-19) vaccines were received. Our aim was to longitudinally evaluate coagulation profiles in a...